The Role of the Somatotrophic Axis in Neuroprotection and Neuroregeneration of the Addictive Brain

International Review of Neurobiology

Volumn 88, Issue C, 2009, Pages 399-427

  Nyberg, Fred ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; JANUS KINASE; LACTATE DEHYDROGENASE; PROTEIN BCL 2; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AGING; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN DAMAGE; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; CHOROID PLEXUS; COGNITIVE DEFECT; EDEMA; GABAERGIC SYSTEM; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEROIN DEPENDENCE; HIPPOCAMPUS; HUMAN; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; SPINAL CORD INJURY; SUBSTANCE ABUSE;

ALCOHOLIC BEVERAGES; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NERVE REGENERATION; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; OPIOID-RELATED DISORDERS; SIGNAL TRANSDUCTION; SUBSTANCE-RELATED DISORDERS;

EID: 71749103464     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(09)88014-8     Document Type: Review

References (124)

1. Aberg M.A., Aberg N.D., Hedbäcker H., Oscarsson J., and Eriksson P.S. Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J. Neurosci. 20 8 (2000) 2896-2903
2. Aberg N.D., Brywe K.G., and Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci. World J. 6 (2006) 53-80 (Review)
3. Aberg N.D., Johansson I., Aberg M.A., Lind J., Johansson U.E., Cooper-Kuhn C.M., Kuhn H.G., and Isgaard J. Peripheral administration of GH induces cell proliferation in the brain of adult hypophysectomized rats. J. Endocrinol. 201 1 (2009) 141-150
4. Aimaretti G., and Ghigo E. Traumatic brain injury and hypopituitarism. Sci. World J. 5 (2005) 777-781 (Review)
5. Ajo R., Cacicedo L., Navarro C., and Sanchez-Franco F. Growth hormone action on proliferation and differentiation of cerebral cortical cells from fetal rat. Endocrinology 144 3 (2003) 1086-1097
6. Anderson M.F., Aberg M.A., Nilsson M., and Eriksson P.S. Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. Brain Res. Dev. Brain Res. 134 1-2 (2002) 115-122
7. Andersson K., Fuxe K., Eneroth P., Isaksson O., Nyberg F., and Roos P. Rat growth hormone and hypothalamic catecholamine nerve terminal systems. Evidence for rapid and discrete reductions in dopamine and noradrenaline levels and turnover in the median eminence of the hypophysectomized male rat. Eur. J. Pharmacol. 95 3-4 (1983) 271-275
8. Araujo D.M., Lapchak P.A., Collier B., Chabot J.G., and Quirion R. Insulin-like growth factor-1 (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Res. 484 1-2 (1989) 130-138
9. Arguello A.A., Harburg G.C., Schonborn J.R., Mandyam C.D., Yamaguchi M., and Eisch A.J. Time course of morphine's effects on adult hippocampal subgranular zone reveals preferential inhibition of cells in S phase of the cell cycle and a subpopulation of immature neurons. Neuroscience 157 1 (2008) 70-79
10. Azcoitia I., Perez-Martin M., Salazar V., Castillo C., Ariznavarreta C., Garcia-Segura L.M., and Tresguerres J.A. Growth hormone prevents neuronal loss in the aged rat hippocampus. Neurobiol. Aging 26 5 (2005) 697-703
11. Behan L.A., Phillips J., Thompson C.J., and Agha A. Neuroendocrine disorders after traumatic brain injury. J. Neurol. Neurosurg. Psychiatry 79 7 (2008) 753-759 (Review)
12. Benfenati F. Synaptic plasticity and the neurobiology of learning and memory. Acta Biomed. 78 Suppl. 1 (2007) 58-66
13. Bengtsson B.A., Edén S., Lönn L., Kvist H., Stokland A., Lindstedt G., Bosaeus I., Tölli J., Sjöström L., and Isaksson O.G. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J. Clin. Endocrinol. Metab. 76 2 (1993) 309-317
14. Bennett E., McGuinness L., Gevers E.F., Thomas G.B., Robinson I.C., Davey H.W., and Luckman S.M. Hypothalamic STAT proteins: Regulation of somatostatin neurones by growth hormone via STAT5b. J. Neuroendocrinol. 17 3 (2005) 186-194
15. Bhat R.S., Bhaskaran M., Mongia A., Hitosugi N., and Singhal P.C. Morphine-induced macrophage apoptosis: Oxidative stress and strategies for modulation. J. Leukoc. Biol. 75 6 (2004) 1131-1138
16. Björk S., Jönsson B., Westphal O., and Levin J.E. Quality of life of adults with growth hormone deficiency: A controlled study. Acta Paediatr. Scand. Suppl. 356 (1989) 55-59 discussion 60, 73-74
17. Bohannon N.J., Corp E.S., Wilcox B.J., Figlewicz D.P., Dorsa D.M., and Baskin D.G. Localization of binding sites for insulin-like growth factor-I (IGF-I) in the rat brain by quantitative autoradiography. Brain Res. 444 2 (1988) 205-213
18. Boronat M.A., García-Fuster M.J., and García-Sevilla J.A. Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain. Br. J. Pharmacol. 134 6 (2001) 1263-1270
19. Burman P., Hetta J., Wide L., Månsson J.E., Ekman R., and Karlsson F.A. Growth hormone treatment affects brain neurotransmitters and thyroxine [see comment]. Clin. Endocrinol. (Oxf). 44 3 (1996 Mar) 319-324
20. Burman P., and Deijen J.B. Quality of life and cognitive function in patients with pituitary insufficiency. Psychother. Psychosom. 67 3 (1998) 154-167 (Review)
21. Burton K.A., Kabigting E.B., Clifton D.K., and Steiner R.A. Growth hormone receptor messenger ribonucleic acid distribution in the adult male rat brain and its colocalization in hypothalamic somatostatin neurons. Endocrinology 131 2 (1992) 958-963
22. Büttner A., Mall G., Penning R., and Weis S. The neuropathology of heroin abuse. Forensic Sci. Int. 113 1-3 (2000) 435-442
23. Carro E., Trejo J.L., Fernandez S., Fernandez A.M., and Torres-Aleman I. Insulin-like growth factor-1 and neuroprotection. In: Nyberg F. (Ed). The Somatotrophic Axis in Brain Function (2006), Elsevier Academic Press, San Diego, CA 209-215
24. Carvalho F. How bad is accelerated senescence in consumers of drugs of abuse?. Adicciones 21 2 (2009) 99-104
25. Climent E., Pascual M., Renau-Piqueras J., and Guerri C. Ethanol exposure enhances cell death in the developing cerebral cortex: Role of brain-derived neurotrophic factor and its signaling pathways. J. Neurosci. Res. 68 2 (2002) 213-225
26. Coculescu M. Blood-brain barrier for human growth hormone and insulin-like growth factor-I. J. Pediatr. Endocrinol. Metab. 12 2 (1999) 113-124 (Review)
27. Creyghton W.M., van Dam P.S., and Koppeschaar H.P. The role of the somatotrophic system in cognition and other cerebral functions. Semin. Vasc. Med. 4 2 (2004) 167-172 (Review)
28. Donahue C.P., Kosik K.S., and Shors T.J. Growth hormone is produced within the hippocampus where it responds to age, sex, and stress. Proc. Natl. Acad. Sci. USA 103 15 (2006) 6031-6036
29. Eisch A.J., and Harburg G.C. Opiates, psychostimulants, and adult hippocampal neurogenesis: Insights for addiction and stem cell biology. Hippocampus 16 3 (2006) 271-286 (Review)
30. Eisch A.J., Barrot M., Schad C.A., Self D.W., and Nestler E.J. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc. Natl. Acad. Sci. USA 97 13 (2000) 7579-7584
31. Ersche K.D., Clark L., London M., Robbins T.W., and Sahakian B.J. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 31 5 (2006) 1036-1047
32. Falleti M.G., Maruff P., Burman P., and Harris A. The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: A meta-analysis of the current literature. Psychoneuroendocrinology 31 6 (2006) 681-691
33. Ganong W.F. Circumventricular organs: Definition and role in the regulation of endocrine and autonomic function. Clin. Exp. Pharmacol. Physiol. 27 5-6 (2000) 422-427 (Review)
34. Gibson E.M., Henson E.S., Haney N., Villanueva J., and Gibson S.B. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release. Cancer Res. 62 2 (2002) 488-496
35. Giordano R., Bonelli L., Marinazzo E., Ghigo E., and Arvat E. Growth hormone treatment in human ageing: Benefits and risks. Hormones (Athens) 7 2 (2008) 133-139 (Review)
36. Glass J.M., Buu A., Adams K.M., Nigg J.T., Puttler L.I., Jester J.M., and Zucker R.A. Effects of alcoholism severity and smoking on executive neurocognitive function. Addiction 104 1 (2009) 38-48
37. Gould E., Beylin A., Tanapat P., Reeves A., and Shors T.J. Learning enhances adult neurogenesis in the hippocampal formation. Nat. Neurosci. 2 3 (1999) 260-265
38. Gualco E., Wang J.Y., Del Valle L., Urbanska K., Peruzzi F., Khalili K., Amini S., and Reiss K. IGF-IR in neuroprotection and brain tumors. Front. Biosci. 14 (2009) 352-375 (Review)
39. Guan J. Insulin-like growth factor-1 and its derivatives: Potential pharmaceutical application for ischemic brain injury. Recent Pat. CNS Drug. Discov. 3 2 (2008) 112-127 (Review)
40. Guerra D., Sole A., Cami J., and Tobena A. Neuropsychological performance in opiate addicts after rapid detoxification. Drug Alcohol Depend. 20 (1987) 261-270
41. Han V.K. Is the central nervous system a target for growth hormone and insulin-like growth factors?. Acta Paediatr. Suppl. 411 (1995) 3-8 (Review)
42. Harburg G.C., Hall F.S., Harrist A.V., Sora I., Uhl G.R., and Eisch A.J. Knockout of the μ opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons. Neuroscience 144 1 (2007) 77-87
43. Harvey S., Baudet M.L., and Sanders E.J. Growth hormone and cell survival in the neural retina: Caspase dependence and independence. Neuroreport 17 16 (2006) 1715-1718
44. Hauser K.F., Houdi A.A., Turbek C.S., Elde R.P., and Maxson III W. Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: Differential impact of mu and delta receptor activation on proliferation and neurite elongation. Eur. J. Neurosci. 12 4 (2000) 1281-1293
45. Hojvat S., Baker G., Kirsteins L., and Lawrence A.M. Growth hormone (GH) immunoreactivity in the rodent and primate CNS: Distribution, characterization and presence posthypophysectomy. Brain Res. 239 2 (1982) 543-557
46. Hu S., Sheng W.S., Lokensgard J.R., and Peterson P.K. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 42 (2002) 829-836
47. Isgaard J., Aberg D., and Nilsson M. Protective and regenerative effects of the GH/IGF-I axis on the brain. Minerva Endocrinol. 32 2 (2007) 103-113 (Review)
48. Johansson J.O., Larson G., Andersson M., Elmgren A., Hynsjo L., Lindahl A., Lundberg P.A., Isaksson O.G., Lindstedt S., and Bengtsson B.A. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology 61 1 (1995) 57-66
49. Kajta M., Trotter A., Lasoń W., and Beyer C. Effect of NMDA on staurosporine-induced activation of caspase-3 and LDH release in mouse neocortical and hippocampal cells. Brain Res. Dev. Brain Res. 160 1 (2005) 40-52
50. Kasagi Y., Tokita R., Nakata T., Imaki T., and Minami S. Human growth hormone induces SOCS3 and CIS mRNA increase in the hypothalamic neurons of hypophysectomized rats. Endocr. J. 51 2 (2004) 145-154
51. Kastin A.J., Akerstrom V., and Pan W. Validity of multiple-time regression analysis in measurement of tritiated and iodinated leptin crossing the blood-brain barrier: Meaningful controls. Peptides 22 12 (2001) 2127-2136
52. Kim B., and Feldman E.L. Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis. Apoptosis 14 5 (2009) 665-673
53. Kreitschmann-Andermahr I., Poll E.M., Reineke A., Gilsbach J.M., Brabant G., Buchfelder M., Fassbender W., Faust M., Kann P.H., and Wallaschofski H. Growth hormone deficient patients after traumatic brain injury-Baseline characteristics and benefits after growth hormone replacement-An analysis of the German KIMS database. Growth Horm. IGF Res. 18 6 (2008) 472-478
54. Kuribayashi K., Mayes P.A., and El-Deiry W.S. What are caspases 3 and 7 doing upstream of the mitochondria?. Cancer Biol. Ther. 5 7 (2006) 763-765 (Review)
55. Lai Z., Emtner M., Roos P., and Nyberg F. Characterization of putative growth hormone receptors in human choroid plexus. Brain Res. 546 2 (1991) 222-226
56. Lai Z., Roos P., Olsson Y., Larsson C., and Nyberg F. Characterization of prolactin receptors in human choroid plexus. Neuroendocrinology 56 2 (1992) 225-233
57. Lai Z., Roos P., Zhai O., Olsson Y., Fholenhag K., Larsson C., and Nyberg F. Age-related reduction of human growth hormone-binding sites in the human brain. Brain Res. 621 2 (1993) 260-266
58. Laron Z. Insulin and the brain. Arch. Physiol. Biochem. 115 2 (2009) 112-116
59. Laursen T., Jørgensen J.O., and Christiansen J.S. The management of adult growth hormone deficiency syndrome. Expert Opin. Pharmacother. 9 14 (2008) 2435-2450 (Review)
60. Laviola L., Natalicchio A., and Giorgino F. The IGF-I signaling pathway. Curr. Pharm. Des. 13 7 (2007) 663-669 (Review)
61. Le Grevés M. Growth hormone receptor message in the rat and human central nervous system. In: Nyberg F. (Ed). The Somatotrophic Axis in Brain Function (2006), Elsevier Academic Press, San Diego, CA 99-107
62. Le Grevés M., Fhölenhag K., Zhou Q., Berg M., Meyerson B., and Nyberg F. Effects of recombinant human growth hormone on learning and memory function. Growth Horm. IGF Res. 10 (2000) 130
63. Le Grevés M., Steensland P., Le Grevés P., and Nyberg F. Growth hormone induces age-dependent alteration in the expression of hippocampal growth hormone receptor and N-methyl-d-aspartate receptor subunits gene transcripts in male rats. Proc. Natl. Acad. Sci. USA 99 10 (2002) 7119-7123
64. Le Grevés M., Le Grevés P., and Nyberg F. Age-related effects of IGF-1 on the NMDA-, GH- and IGF-1-receptor mRNA transcripts in the rat hippocampus. Brain Res. Bull. 65 5 (2005) 369-374
65. Le Greves M., Zhou Q., Berg M., Le Greves P., Fholenhag K., Meyerson B., and Nyberg F. Growth hormone replacement in hypophysectomized rats affects spatial performance and hippocampal levels of NMDA receptor subunit and PSD-95 gene transcript levels. Exp. Brain Res. 173 2 (2006) 267-273
66. Lichtenwalner R.J., Forbes M.E., Bennett S.A., Lynch C.D., Sonntag W.E., and Riddle D.R. Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis. Neuroscience 107 4 (2001) 603-613
67. Lobie P.E., García-Aragón J., Lincoln D.T., Barnard R., Wilcox J.N., and Waters M.J. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Brain Res. Dev. Brain Res. 74 2 (1993) 225-233
68. Mao J., Sung B., Ji R.R., and Lim G. Neuronal apoptosis associated with morphine tolerance: Evidence for an opioid-induced neurotoxic mechanism. J. Neurosci. 22 (2002) 7650-7661
69. McMillan C.V., Bradley C., Gibney J., Healy M.L., Russell-Jones D.L., and Sönksen P.H. Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency. Clin. Endocrinol. (Oxford) 59 4 (2003) 467-475
70. Melmed S., Yamashita S., Yamasaki H., Fagin J., Namba H., Yamamoto H., Weber M., Morita S., Webster J., and Prager D. IGF-I receptor signalling: Lessons from the somatotroph. Recent Prog. Horm. Res. 51 (1996) 189-215 discussion 215-216 (Review)
71. Mustafa A., Adem A., Roos P., and Nyberg F. Sex differences in binding of human growth hormone to rat brain. Neurosci. Res. 19 1 (1994) 93-99
72. Mustafa A., Nyberg F., Bogdanovic N., Islam A., Roos P., and Adem A. Somatogenic and lactogenic binding sites in rat brain and liver: Quantitative autoradiographic localization. Neurosci. Res. 20 3 (1994) 257-263
73. Nash R.J., Heimburg-Molinaro J., and Nash R.J. Heparin binding epidermal growth factor-like growth factor reduces ethanol-induced apoptosis and differentiation in human embryonic stem cells. Growth Factors. Aug 4 1 (2009) [Epub ahead of print]
74. Nilsson A.G., Svensson J., and Johannsson G. Management of growth hormone deficiency in adults. Growth Horm. IGF Res. 17 6 (2007) 441-462
75. Noteborn H.P., van Balen P.P., van der Gugten A.A., Hart I.C., Ebels I., and Salemink C.A. Presence of immunoreactive growth hormone and prolactin in the ovine pineal gland. J. Pineal Res. 14 1 (1993) 11-22
76. Nyberg F. Growth hormone in the brain: Characteristics of specific brain targets for the hormone and their functional significance. Front. Neuroendocrinol. 21 4 (2000) 330-348
77. Nyberg F. Growth hormone and insulin-like growth factor-1 in human cerebrospinal fluid. In: Nyberg F. (Ed). The Somatotrophic Axis in Brain Function (2006), Elsevier Academic Press, San Diego, CA 69-74
78. Nyberg F. Growth hormone and brain function. In: Ranke M.B., Price D.A., and Reiter E.O. (Eds). Growth Hormone Therapy in Pediatrics. 20 Years of KIGS (2007), Basel, Karger 450-460
79. Nyberg F., and Burman P. Growth hormone and its receptors in the central nervous system-Location and functional significance. Horm. Res. 45 1-2 (1996) 18-22 (Review)
80. Nyberg F., and Sharma H.S. Repeated topical application of growth hormone attenuates blood-spinal cord barrier permeability and edema formation following spinal cord injury: An experimental study in the rat using Evans blue, ([125])I-sodium and lanthanum tracers. Amino Acids 23 1-3 (2002) 231-239
81. Nyberg F., Nalén B., Fhölenhag K., Fryklund L., and Albertsson-Wikland K. Enzymatic release of peptide fragments from human growth hormone which displace (H)-dihydromorphine from rat brain opioid receptors. J. Endocrinol. Invest. 12 Suppl. 2 (1989) 140
82. O'Kusky J.R., Ye P., and D'Ercole A.J. Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. J. Neurosci. 20 22 (2000) 8435-8442
83. Opanashuk L.A., and Hauser K.F. Opposing actions of the EGF family and opioids: Heparin binding-epidermal growth factor (HB-EGF) protects mouse cerebellar neuroblasts against the antiproliferative effect of morphine. Brain Res. 804 1 (1998) 87-94
84. Orellana D.I., Quintanilla R.A., Gonzalez-Billault C., and Maccioni R.B. Role of the JAKs/STATs pathway in the intracellular calcium changes induced by interleukin-6 in hippocampal neurons. Neurotox Res. 8 3-4 (2005) 295-304
85. Pan W., and Kastin A.J. Interactions of IGF-1 with the blood-brain barrier in vivo and in situ. Neuroendocrinology 72 3 (2000) 171-178
86. Pan W., Yu Y., Cain C.M., Nyberg F., Couraud P.O., and Kastin A.J. Permeation of growth hormone across the blood-brain barrier. Endocrinology 146 11 (2005) 4898-48904
87. Parissis J.T., Adamopoulos S., Karatzas D., Paraskevaidis J., Livanis E., and Kremastinos D. Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodelling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy. Eur. J. Cardiovasc. Prev. Rehabil. 12 2 (2005) 164-168
88. Philippou A., Halapas A., Maridaki M., and Koutsilieris M. Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy. J. Musculoskelet. Neuronal. Interact. 7 3 (2007) 208-218 (Review)
89. Rami A. Ischemic neuronal death in the rat hippocampus: The calpain-calpastatin-caspase hypothesis. Neurobiol. Dis. 13 2 (2003) 75-88
90. Ramsey M.M., Weiner J.L., Moore T.P., Carter C.S., and Sonntag W.E. Growth hormone treatment attenuates age-related changes in hippocampal short-term plasticity and spatial learning. Neuroscience 129 1 (2004) 119-127
91. Ransome M.I., Goldshmit Y., Bartlett P.F., Waters M.J., and Turnley A.M. Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness. Eur. J. Neurosci. 19 8 (2004) 2069-2079
92. Sanders E.J., Baudet M.L., Parker E., and Harvey S. Signaling mechanisms mediating local GH action in the neural retina of the chick embryo. Gen. Comp. Endocrinol. 163 1-2 (2009) 63-69
93. Sanders E.J., Parker E., and Harvey S. Endogenous growth hormone in human retinal ganglion cells correlates with cell survival. Mol. Vis. 15 (2009) 920-926
94. Sanders E.J., Lin W.Y., Parker E., and Harvey S. Growth hormone expression and neuroprotective activity in a quail neural retina cell line. Gen. Comp. Endocrinol. (2009) June 17 [Epub ahead of print]
95. Sara V.R., Hall K., Von Holtz H., Humbel R., Sjögren B., and Wetterberg L. Evidence for the presence of specific receptors for insulin-like growth factors 1 (IGE-1) and 2 (IGF-2) and insulin throughout the adult human brain. Neurosci. Lett. 34 1 (1982) 39-44
96. Scheepens A., Williams C.E., Breier B.H., Guan J., and Gluckman P.D. A role for the somatotrophic axis in neural development, injury and disease. J. Pediatr. Endocrinol. Metab. 13 Suppl. 6 (2000) 1483-1491 (Review)
97. Scott H.J., Stebbing M.J., Walters C.E., McLenachan S., Ransome M.I., Nichols N.R., and Turnley A.M. Differential effects of SOCS2 on neuronal differentiation and morphology. Brain Res. 1067 1 (2006) 138-145
98. Seiler A.E., Ross B.N., Green J.S., and Rubin R. Differential effects of ethanol on insulin-like growth factor-I receptor signaling. Alcohol Clin. Exp. Res. 24 2 (2000) 140-148
99. Shafiei F., Herington A.C., and Lobie P.E. Mechanism of signal transduction utilized by growth hormone. In: Nyberg F. (Ed). The Somatotrophic Axis in Brain Function (2006), Elsevier Academic Press, San Diego, CA 39-49
100. Sherlock M., and Toogood A.A. Aging and the growth hormone/insulin like growth factor-1 axis. Pituitary 10 2 (2007) 189-203
101. Smith P.F. Neuroprotection against hypoxia-ischemia by insulin-like growth factor-I (IGF-I). IDrugs 6 12 (2003) 1173-1177 (Review)
102. Sonntag W.E., Lynch C., Thornton P., Khan A., Bennett S., and Ingram R. The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing. J. Anat. 197 Pt. 4 (2000) 575-585 (Review)
103. Sonntag W.E., Bennett S.A., Khan A.S., Thornton P.L., Xu X., Ingram R.L., and Brunso-Bechtold J.K. Age and insulin-like growth factor-1 modulate N-methyl-D-aspartate receptor subtype expression in rats. Brain Res. Bull. 51 4 (2000) 331-338
104. Sonntag W.E., Ramsey M., and Carter C.S. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res. Rev. 4 2 (2005) 195-212 (Review)
105. Spain J.W., and Newsom G.C. Chronic opioids impair acquisition of both radial maze and Y-maze choice escape. Psychopharmacology (Berl) 105 1 (1991) 101-106
106. Stabler B. Impact of growth hormone (GH) therapy on quality of life along the lifespan of GH-treated patients. Horm. Res. 56 Suppl. 1 (2001) 55-58
107. Sun L.Y., Al-Regaiey K., Masternak M.M., Wang J., and Bartke A. Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiol. Aging 26 6 (2005) 929-937
108. Svensson J., Johansson G., and Bengtsson B.A. Body composition and quality of life as markers of the efficacy of growth hormone replacement therapy in adults. Horm. Res. 55 Suppl. 2 (2001) 55-60 (Review)
109. Svensson A.L., Bucht N., Hallberg M., and Nyberg F. Reversal of opiate-induced apoptosis by human recombinant growth hormone in murine foetus primary hippocampal neuronal cell cultures. Proc. Natl. Acad Sci. USA 105 20 (2008) 7304-7308
110. Tateno M., Ukai W., Ozawa H., Yamamoto M., Toki S., Ikeda H., and Saito T. Ethanol inhibition of neural stem cell differentiation is reduced by neurotrophic factors. Alcohol Clin. Exp. Res. 28 8 Suppl. (2004) 134S-138S Proceedings
111. Thornwall M., Chhajlani V., Le Grevès P., and Nyberg F. Detection of growth hormone receptor mRNA in an ovine choroid plexus epithelium cell line. Biochem. Biophys. Res. Commun. 217 1 (1995) 349-353
112. Thornwall-Le Grevés M., Zhou Q., Lagerholm S., Huang W., Le Grevés P., and Nyberg F. Morphine decreases the levels of the gene transcripts of growth hormone receptor and growth hormone binding protein in the male rat hippocampus and spinal cord. Neurosci. Lett. 304 1-2 (2001) 69-72
113. Trejo J.L., Carro E., Garcia-Galloway E., and Torres-Aleman I. Role of insulin-like growth factor I signaling in neurodegenerative diseases. J. Mol. Med. 82 3 (2004) 156-162 (Review)
114. van Dam P.S., Aleman A., de Vries W.R., Deijen J.B., van der Veen E.A., de Haan E.H., and Koppeschaar H.P. Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Horm. IGF Res. 10 Suppl. B (2000) S69-S73 (Review)
115. van Nieuwpoort I.C., and Drent M.L. Cognition in the adult with childhood-onset GH deficiency. Eur. J. Endocrinol. 159 Suppl. 1 (2008) S53-S57
116. Walsh R.J., Slaby F.J., and Posner B.I. A receptor-mediated mechanism for the transport of prolactin from blood to cerebrospinal fluid. Endocrinology 120 5 (1987) 1846-1850
117. Walsh R.J., Mangurian L.P., and Posner B.I. The distribution of lactogen receptors in the mammalian hypothalamus: an in vitro autoradiographic analysis of the rabbit and rat. Brain Res. 530 1 (1990) 1-11
118. Webb S.M., and Badia X. Quality of life in growth hormone deficiency and acromegaly. Endocrinol. Metab. Clin. North Am. 36 1 (2008) 221-232 (Review)
119. Werther G.A., Hogg A., Oldfield B.J., McKinley M.J., Figdor R., and Mendelsohn F.A. Localization and characterization of insulin-like growth factor-I receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry: A distinct distribution from insulin receptors. J. Neuroendocrinol. 1 5 (1989) 369-377
120. Wine R.N., McPherson C.A., and Harry G.J. IGF-1 and pAKT signaling promote hippocampal CA1 neuronal survival following injury to dentate granule cells. Neurotox Res. 16 3 (2009) 280-292
121. Winkler T., Sharma H.S., Stålberg E., Badgaiyan R.D., Westman J., and Nyberg F. Growth hormone attenuates alterations in spinal cord evoked potentials and cell injury following trauma to the rat spinal cord. An experimental study using topical application of rat growth hormone. Amino Acids 19 1 (2000) 363-371
122. Zhai Q., Lai Z., Roos P., and Nyberg F. Characterization of growth hormone binding sites in rat brain. Acta Paediatr. Suppl. 406 (1994) 92-95
123. Zhai Q.Z., Lai Z., Yukhananov R., Roos P., and Nyberg F. Decreased binding of growth hormone in the rat hypothalamus and choroid plexus following morphine treatment. Neurosci. Lett. 184 2 (1995) 82-85
124. Zheng W.H., and Quirion R. Glutamate acting on N-methyl-d-aspartate receptors attenuates insulin-like growth factor-1 receptor tyrosine phosphorylation and its survival signaling properties in rat hippocampal neurons. J. Biol. Chem. 284 2 (2009) 855-861